Inhibition of renal alkaline phosphatase by cimetidine. 2011

Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
BioResearch Lab, Faculty of Biological Sciences, Shahid Beheshti University G.C, Iran. D_MTehrani@sbu.ac.ir

Alkaline phosphatase (ALP) belongs to hydrolase group of enzymes. It is responsible for removing phosphate groups from many types of molecules, including nucleotides and proteins. Cimetidine (trade name Tagamet) is an antagonist of histamine H2-receptor that inhibits the production of gastric acid. Cimetidine is used for the treatment of gastrointestinal diseases. In this study the inhibitory effect of cimetidine on mouse renal ALP activity was investigated. Our results showed that cimetidine can inhibit ALP by uncompetitive inhibition. In the absence of inhibitor the V(max) and K(m) of the enzyme were found to be 13.7 mmol/mg prot.min and 0.25 mM, respectively. Both the Vmax and Km of the enzyme decreased with increasing cimetidine concentrations (0- 1.2 mM). The Ki and IC(50) of cimetidine were determined to be about 0.5 mM and 0.52 mM, respectively.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
March 1963, Revista espanola de fisiologia,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
July 1982, British medical journal (Clinical research ed.),
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
January 1953, Bollettino della Societa italiana di biologia sperimentale,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
October 1981, Clinica chimica acta; international journal of clinical chemistry,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
November 1988, Biochemical pharmacology,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
February 1970, The Biochemical journal,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
February 1980, Clinica chimica acta; international journal of clinical chemistry,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
September 1983, Clinica chimica acta; international journal of clinical chemistry,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
April 1979, Biochemical pharmacology,
Dariush Minai-Tehrani, and Somayeh Khodai, and Somayeh Aminnaseri, and Saeed Minoui, and Zahra Sobhani-Damavadifar, and Sana Alavi, and Raheleh Osmani, and Shiva Ahmadi
July 1951, The Biochemical journal,
Copied contents to your clipboard!